Ambee’s global pollen dataset provides precision-level environmental intelligence on allergenic activity, built for real-world decision systems across healthcare, consumer health, retail, and analytics platforms. The dataset is powered by a blend of environmental signals and proprietary modeling techniques, designed to reflect real-world conditions with high spatial and temporal accuracy. Pollen outputs are available at both category level (tree, grass, weed) and species level, with hourly updates and validated forecast windows extending up to 30 days in advance. Every forecast is benchmarked against seasonal cycles and adjusted by geography for local accuracy. Ambee maintains a pristine historical pollen archive spanning more than a decade, supporting long-term analysis, demand modeling, and climate-aware planning. All data is spatially and temporally complete, queryable at lat-lon resolution or mapped to ZIP codes, postcodes, DMAs, and custom geographies. Core variables include: • Pollen count and risk by species • Category-level breakdowns: tree, grass, weed • Hourly and daily forecast feeds • Historical pollen records spanning multiple decades

Built for integration into platforms where environmental triggers impact behavior, outcomes, or demand, Ambee’s pollen data supports everything from personalized digital health recommendations to allergy season inventory forecasting.

Air Quality & Pollen Forecast For Fortaleza
This dataset falls under the category Environmental Data Air Quality Data.
It contains the following data: Air data, particles and gases
This dataset was scouted on 2022-02-23 as part of a data sourcing project conducted by TUMI. License information might be outdated: Check original source for current licensing. The data can be accessed using the following URL / API Endpoint: https://www.meteoblue.com/en/weather/outdoorsports/airquality/fortaleza_brazil_3399415See URL for data access and license information.

The AQ eLichens API can be divided into three main products:

Geolocated API: choose a specific latitude and longitude anywhere in the world, and obtain historic, current and future air quality description in terms of main pollutants concentration, pollen concentration and air quality indexes Street-level locations API: through this API, you can obtain summary measurements (minimum, maximum and average) coming from a hyper-local Air Quality model powered by eLichens for + 300 locations around the world where this model is deployed. Local Agency Stations API: through this API, you can obtain measurements and forecasts of + 8000 local agency stations around the world.

Twenty-two propolis samples produced by Apis mellifera L. in an area of the Semiarid region the the State of Bahia (Agreste of Alagoinhas), Brazil, were palynologically analyzed and quantified regarding their levels of total phenolic compounds. These samples were processed using the acetolysis technique with the changes suggested for use with propolis. We found 59 pollen types belonging to 19 families and 36 genera. The family Fabaceae was the most representative in this study with nine pollen types, followed by the family Asteraceae with seven types. The typesMikania and Mimosa pudica occurred in all samples analyzed. The types Mimosa pudica andEucalyptus had frequency of occurrence above 50% in at least one sample. The highest similarity index (c. 72%) occurred between the samples ER1 and ER2, belonging to the municipality of Entre Rios. Samples from the municipality of Inhambupe displayed the highest (36.78±1.52 mg/g EqAG) and lowest (7.68 ± 2.58 mg/g EqAG) levels of total phenolic compounds. Through the Spearman Correlation Coefficient we noticed that there was a negative linear correlation between the types Mimosa pudica (rs = -0.0419) and Eucalyptus (rs = -0.7090) with the profile of the levels of total phenolic compounds of the samples.

Loratadine API Market Outlook

The global Loratadine API market size was valued at approximately USD 340 million in 2023 and is expected to reach USD 510 million by 2032, growing at a compound annual growth rate (CAGR) of 4.6% from 2024 to 2032. This robust growth can be attributed to several factors including the rising prevalence of allergies, increasing awareness of over-the-counter (OTC) medications, and advancements in pharmaceutical research and development activities.

One of the primary drivers of the Loratadine API market is the growing incidence of allergic conditions globally. As urbanization and pollution levels rise, the prevalence of allergies has increased significantly, leading to a higher demand for effective antihistamine treatments like Loratadine. Additionally, the shift towards self-medication practices has bolstered the demand for OTC antihistamines, further propelling market growth. The convenience and accessibility of OTC medications have made Loratadine a preferred choice among consumers who seek quick relief from allergy symptoms without needing a prescription.

Another key growth factor is the continuous advancements in pharmaceutical formulations and drug delivery systems. Innovations in drug development have led to improved efficacy and reduced side effects of Loratadine, making it more appealing to both consumers and healthcare providers. Pharmaceutical companies are investing heavily in R&D to develop novel formulations and expand their product portfolios, which is expected to drive market growth in the coming years. Additionally, the increasing focus on personalized medicine and the development of combination therapies are anticipated to create new opportunities for Loratadine API in the pharmaceutical industry.

The expanding geriatric population is also contributing to the growth of the Loratadine API market. Older adults are more susceptible to allergic reactions and often require long-term management of their symptoms. This demographic shift has led to an increased demand for antihistamine medications, including Loratadine. Moreover, rising healthcare expenditure and improved access to healthcare services in emerging economies are expected to boost the market further. Governments and healthcare organizations are implementing initiatives to enhance the availability and affordability of essential medicines, thereby supporting market growth.

Levocetirizine Hydrochloride, another prominent antihistamine, is gaining traction in the pharmaceutical industry due to its effectiveness in treating allergic conditions. Unlike Loratadine, Levocetirizine Hydrochloride is a third-generation antihistamine, known for its reduced sedative effects and enhanced potency. This makes it a preferred choice for patients who require long-term management of allergy symptoms without the drowsiness associated with first-generation antihistamines. The growing awareness of Levocetirizine Hydrochloride's benefits is contributing to its increased adoption in both prescription and OTC markets. As pharmaceutical companies continue to explore new formulations, Levocetirizine Hydrochloride is expected to play a significant role in the expanding landscape of allergy treatments.

From a regional perspective, North America dominates the Loratadine API market, accounting for the largest share in 2023. The region's well-established healthcare infrastructure, high prevalence of allergies, and strong presence of major pharmaceutical companies are key factors driving market growth. Europe is also a significant market for Loratadine API, supported by the increasing incidence of allergies and favorable regulatory policies. The Asia Pacific region is expected to witness the highest growth rate during the forecast period, driven by rising healthcare awareness, improving healthcare infrastructure, and increasing disposable incomes. Latin America and the Middle East & Africa are also anticipated to experience steady growth, supported by expanding healthcare access and growing demand for OTC medications.

Product Type Analysis

The Loratadine API market by product type is segmented into powder, granules, and others. The powder segment holds a significant share of the market due to its widespread use in pharmaceutical formulations. Loratadine powder is commonly used in the production of tablets and capsules, which

Chlorphenamine Maleate API Market Outlook

The global Chlorphenamine Maleate API market size was valued at approximately USD 550 million in 2023 and is projected to reach around USD 825 million by 2032, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period. This robust growth is primarily driven by the increasing prevalence of allergic conditions and the widespread use of Chlorphenamine Maleate in over-the-counter medications.

One of the key growth factors of the Chlorphenamine Maleate API market is the rising incidence of allergies worldwide. As urbanization and pollution levels continue to increase, so does the occurrence of allergic reactions. Chlorphenamine Maleate, being an effective antihistamine, is frequently used to treat symptoms of allergic rhinitis, hay fever, and other similar conditions. The expanding global population, coupled with heightened awareness of allergic conditions and their treatments, significantly contributes to the market's expansion.

Another substantial driver of market growth is the extensive use of Chlorphenamine Maleate in pharmaceutical formulations. The compound is a critical ingredient in various medications, including those for colds and flu, which are common ailments. The consistent demand for such medications ensures a steady need for Chlorphenamine Maleate APIs. Additionally, ongoing pharmaceutical research and development activities aimed at enhancing drug efficacy and safety are likely to spur market growth further.

The rise of generic drugs also plays a crucial role in the growth of the Chlorphenamine Maleate API market. As patents for branded medications expire, there is a surge in the production and consumption of generic drugs, which are more affordable. Chlorphenamine Maleate is a key component in many generic formulations, driving its demand. Furthermore, government initiatives to make healthcare more accessible and affordable also bolster the market for generic drugs, indirectly benefiting the Chlorphenamine Maleate API market.

The role of Fexofenadine Hydrochloride in the treatment of allergic conditions is noteworthy. As a second-generation antihistamine, it is known for its efficacy in alleviating symptoms such as sneezing, runny nose, and itchy eyes without causing significant drowsiness. This makes it a preferred choice for individuals who require relief from allergies while maintaining their daily activities. The increasing prevalence of allergic conditions globally has led to a surge in demand for effective antihistamines like Fexofenadine Hydrochloride. Its inclusion in various over-the-counter and prescription medications highlights its importance in the pharmaceutical industry. As research continues to advance, the potential applications and formulations of Fexofenadine Hydrochloride are likely to expand, further boosting its market presence.

From a regional perspective, North America holds a significant share of the Chlorphenamine Maleate API market, driven by high healthcare expenditure, a strong pharmaceutical industry, and widespread awareness of allergic conditions. Europe closely follows, with robust pharmaceutical manufacturing capabilities and a well-established healthcare system. Meanwhile, the Asia Pacific region is expected to witness the fastest growth due to increasing healthcare infrastructure investments, rising disposable incomes, and growing awareness of allergies and their treatments.

Product Type Analysis

The Chlorphenamine Maleate API market is segmented by product type into powder, granules, and others. Each of these product types has distinct applications and market dynamics. The powder form is the most commonly used type due to its versatility in pharmaceutical formulations. It can be easily mixed with other ingredients, ensuring consistent drug quality and efficacy. The ease of handling and storage of powder forms also contributes to their dominance in the market.

The granules segment, although smaller than the powder segment, is gaining traction due to its advantages in specific applications. Granules are particularly useful in controlled-release formulations, which ensure a sustained release of the active ingredient over time. This is beneficial for medications that require long-lasting effects, such as antihistamines used to manage severe allergic reactions. The demand for granules is expected to grow as pharmaceutical companies continue to innovate in drug delivery systems.</p&g

Rupatadine Fumarate API Market Outlook

The global Rupatadine Fumarate API market size was valued at USD 1.2 billion in 2023 and is expected to reach USD 2.1 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period. The growth of this market is primarily driven by increasing demand for antihistamine drugs, which are used to treat allergic conditions. The rising prevalence of allergies and other related conditions globally is a major factor propelling the growth of the Rupatadine Fumarate API market.

The escalating incidence of allergic conditions such as rhinitis, urticaria, and chronic idiopathic urticaria has created a significant demand for effective antihistamine therapies, which in turn boosts the Rupatadine Fumarate API market. Medical advancements and better diagnostic techniques have led to a higher diagnosis rate of these conditions, further contributing to market growth. Additionally, the rise in air pollution and changing environmental conditions have increased the prevalence of allergies, thereby driving the demand for antihistamines and their active pharmaceutical ingredients (API).

Another growth factor for the Rupatadine Fumarate API market is the increasing investment in pharmaceutical research and development (R&D). Companies are continuously exploring innovative solutions and formulations to improve the efficacy and safety of antihistamine drugs. The trend of personalized medicine and targeted drug delivery systems is also encouraging pharmaceutical companies to invest more in R&D, which in turn fuels the demand for high-quality APIs like Rupatadine Fumarate.

The expanding healthcare infrastructure in emerging economies is also a significant driver for this market. Countries in the Asia Pacific and Latin America are witnessing substantial investments in healthcare, leading to better access to medications. Government initiatives to improve healthcare access and the presence of a large patient pool in these regions are expected to provide lucrative opportunities for market growth. Additionally, the increasing awareness regarding the benefits of early diagnosis and treatment of allergic conditions is expected to further augment market expansion.

In the realm of dermatological treatments, Mometasone Furoate API has emerged as a crucial component for managing various skin conditions. This potent corticosteroid is widely utilized in the formulation of topical medications aimed at reducing inflammation and itching associated with conditions like eczema and psoriasis. The demand for Mometasone Furoate API is driven by its efficacy in providing rapid relief from symptoms and its role in enhancing the quality of life for patients suffering from chronic skin ailments. As the prevalence of dermatological conditions continues to rise globally, the market for Mometasone Furoate API is expected to witness significant growth, supported by ongoing research and development efforts to improve its formulations and delivery mechanisms.

Regionally, North America and Europe dominate the Rupatadine Fumarate API market, driven by a high prevalence of allergic conditions, robust healthcare infrastructure, and strong presence of major pharmaceutical companies. The Asia Pacific region is expected to witness the highest growth during the forecast period, attributed to the increasing incidence of allergies, rising healthcare expenditure, and growing pharmaceutical industry in countries like China and India. Latin America and Middle East & Africa are also anticipated to exhibit considerable growth, driven by improving healthcare infrastructure and increasing awareness about allergic conditions.

Product Type Analysis

The Rupatadine Fumarate API market is segmented by product type into powder, granules, and others. The powder segment holds the largest market share owing to its widespread usage in pharmaceutical formulations. Powders are easy to handle, store, and transport, making them a preferred choice for many pharmaceutical companies. Additionally, the versatility of powders allows them to be used in various drug formulations, including tablets, capsules, and suspensions, further driving their demand.

Granules, on the other hand, are gaining popularity due to their ease of use in pediatric and geriatric formulations. Granules can be easily mixed with food or liquids, making them more palatable for patients who have difficulty swallowing pills. This segme

Palynological investigation of a 410 cm long core section from Tso Kar (33°10'N, 78°E, 4527 m a.s.l.), an alpine lake situated in the arid Ladakh area of NW India at the limit of the present-day Indian summer monsoon, was performed in order to reconstruct post-glacial regional vegetation and climate dynamics. The area was covered with alpine desert vegetation from ca. 15.2 to 14 kyr BP (1 kyr=1000 cal. years), reflecting dry and cold conditions. High influx values of long-distance transported Pinus sylvestris type pollen suggest prevailing air flow from the west and northwest. The spread of alpine meadow communities and local aquatic vegetation is a weak sign of climate amelioration after ca. 14 kyr BP. Pollen data (e.g. influx values of Pinus roxburghii type and Quercus) suggest that this was due to a strengthening of the summer monsoon and the reduced activity of westerly winds. The further spread of Artemisia and species-rich meadows occurred in response to improved moisture conditions between ca. 12.9 and 12.5 kyr BP. The subsequent change towards drier desert-steppe vegetation likely indicates more frequent westerly disturbances and associated snowfalls, which favoured the persistence of alpine meadows on edaphically moist sites. The spread of Chenopodiaceae-dominated vegetation associated with an extremely weak monsoon occurred at ca. 12.2-11.8 kyr BP during the Younger Dryas interstadial. A major increase in humidity is inferred from the development of Artemisia-dominated steppe and wet alpine meadows with Gentianaceae after the late glacial/early Holocene transition in response to the strengthening of the summer monsoon. Monsoonal influence reached maximum activity in the Tso Kar region between ca. 10.9 and 9.2 kyr BP. The subsequent development of the alpine meadow, steppe and desert-steppe vegetation points to a moderate reduction in the moisture supply, which can be linked to the weaker summer monsoon and the accompanying enhancement of the winter westerly flow from ca. 9.2 to 4.8 kyr BP. The highest water levels of Tso Kar around 8 kyr BP probably reflect combined effect of both monsoonal and westerly influence in the region. An abrupt shift towards aridity in the Tso Kar region occurred after ca. 4.8 kyr BP, as evidenced by an expansion of Chenopodiaceae-dominated desert-steppe. Low pollen influx values registered ca. 2.8-1.3 kyr BP suggest scarce vegetation cover and unfavourable growing conditions likely associated with a further weakening of the Indian Monsoon.

Cetirizine Hydrochloride API Market Outlook

The global market size for Cetirizine Hydrochloride API was valued at approximately USD X million in 2023 and is projected to reach USD Y million by 2032, growing at a CAGR of Z% during the forecast period. The growth of this market is attributed to the increasing prevalence of allergic conditions worldwide, an aging population, and heightened awareness regarding the efficacy of antihistamines.

One of the primary growth factors for the Cetirizine Hydrochloride API market is the surge in allergic conditions such as rhinitis, urticaria, and other skin allergies. With the rise in pollution levels and changing climatic conditions, the incidence of allergic reactions is on the rise. This has led to an increased demand for effective antihistamines like Cetirizine Hydrochloride, which is known for its efficacy and minimal side effects. The consistent increase in such conditions is expected to drive the market significantly during the forecast period.

Another crucial growth driver is the aging global population. As people age, they become more susceptible to various allergic conditions, necessitating the use of antihistamines like Cetirizine Hydrochloride. The elderly population often requires medications that are both effective and have a well-established safety profile, making Cetirizine Hydrochloride a preferable choice. This demographic trend is likely to bolster the market growth in the coming years.

Furthermore, heightened awareness and understanding of allergic conditions among the general populace and healthcare professionals are contributing to market expansion. Educational campaigns and easy access to information have made people more proactive in seeking treatment for allergies. The availability of Cetirizine Hydrochloride in various formulations and its inclusion in over-the-counter medications also make it a popular choice. Such awareness and accessibility are critical factors propelling the market forward.

From a regional standpoint, North America is expected to dominate the Cetirizine Hydrochloride API market, followed by Europe and Asia Pacific. The high prevalence of allergic conditions, well-established healthcare infrastructure, and significant investments in research and development in North America are pivotal factors contributing to the region's market leadership. Similarly, Europe is anticipated to see substantial growth due to the increasing geriatric population and rising awareness about allergy management. Meanwhile, Asia Pacific is projected to exhibit the highest CAGR due to the growing healthcare expenditure and rising prevalence of allergic conditions in countries like India and China.

Product Type Analysis

The Cetirizine Hydrochloride API market can be segmented based on product types into powder, granules, and others. The powder form is expected to hold a significant share of the market due to its widespread use in pharmaceutical formulations. The ease of blending and consistency in dosage make the powder form highly desirable for drug manufacturing. Additionally, it allows for flexibility in creating various dosage forms, such as tablets and capsules, contributing to its dominance in the market.

Granules form another important segment in the Cetirizine Hydrochloride API market. Granules are increasingly preferred in certain pharmaceutical applications due to their ease of handling and improved flow properties compared to powders. These characteristics are particularly beneficial in high-speed tablet manufacturing processes, thus ensuring efficient production. Moreover, granules often exhibit better stability and less dust formation, which are significant advantages in pharmaceutical manufacturing settings.

Other product types, such as solutions and suspensions, are also gaining traction in the market. These forms are particularly useful in pediatric and geriatric medicines where swallowing pills might be challenging. Liquid forms offer an alternative that is easier to consume and can be more accurately dosed. The growing demand for pediatric and geriatric formulations is expected to boost the market share of these alternative forms significantly.

The robustness of the market for different product types can also be attributed to the advancements in pharmaceutical technology. Improved manufacturing processes and innovative formulation techniques have enhanced the quality and efficacy of Cetirizine Hydrochloride API in its various forms. These technological strides ensure that the API can meet the diverse needs

The discovery of a neolithic pile field in the shallow water near the eastern shore of the Degersee confirmed earlier palynological and sedimentological studies stating that early man was active in the region since more than 6000 years. The already available off-site data were freshly assessed, completed by additional data from old and new cores and the interpretations revised. A common time scale for the off-site data and the on-site data was obtained by AMS dating of terrestrial macro remains of the neolithic section of off-site core De_I+De_H. The ages can thus be parallelled with AMS ages of construction timber on-site. Pollen analyses from all cores provide a further time scale. The continuously and densely sampled pollen profile of the profundal zone embracing the entire Late glacial and Holocene serves as a reference. From the Boreal onwards the relative ages are transformed by AMS ages and varve counts into calibrated and absolute. A transect cored close to the neolithic pile field across the lake marl-platform demonstrates its geological architecture in the shallow water since the Lateglacial. Studies of the microfabric of thin sections of drilled cores and of box cores from the excavations demonstrate that neolithic settlements now at 2-3,5 m water depth had been erected on lake marl freshly fallen dry, thus indicating earlier lake levels dropped by 1.5-2 m. The neolithic section of the highly resolved off-site profile in the lake=s profundal zone has laminated and calcareous zones alternating with massive ones. Assemblages of diatoms and concentrations of trace elements changing simultaneously characterise the calcareous sections as deposits of low lake levels that lasted between some 40 and more than 300 years. The ages of discovered lake shore dwellings fall into calcareous segments with low lake levels. From the end of the Upper Atlantic period (F VII) appear Secondary Forest Cycles in the beech forest, a man-made sequence of repeated vegetational development with an identical pattern: With a decrease of beech pollen appear pollen of grasses, herbs and cultural indicators. These are suppressed by the light demanding hazel and birch, those again by ash, and finally by the shade demanding beech forming a new pollen peak. Seven main Forest Cycles are identified In the upper Neolithic period each comprising some 250, 450 or 800 years. They are subdivided into subcycles that can be broken down by very dense sampling in even shorter cycles of decadal length. Farming settlers have caused minor patchy clearances of the beech-mixed-forest with the use of fire. The phases of clearance coincide with peaks of charcoal and low stands of the lake levels. The Secondary Forest Cycles and the continuous occurrence of charcoal prove a continued occupation of the region. Together with the repeated restoration of the beech climax forest they point to pulsating occupation probably associated with dynamic demography. The synchronism of the many palynological, sedimentological and archaeological data point to an external forcing as the climate that affects comprehensively all these proxies. The fluctuations of the activity of the sun as manifested in the residual d14C go largely along with the proxies. The initial clearances at the begin of the forest cycles are linked to low lake levels and negative values of d14C that point to dry and warm phases of a more continental climate type. The subcycles exist independent from climatic changes, indicating that early man acted largely independent from external forces.

Honeybees (Apis mellifera) are important pollinators. Their foraging behaviors are essential to colony sustainability. Sublethal exposure to pesticides such as neonicotinoids can significantly disrupt these behaviors, in particular pollen foraging. We investigated the effects of sublethal doses of the neonicotinoid imidacloprid on honeybee foraging, at both individual and colony levels, by integrating field experiments with artificial intelligence (AI)-based monitoring technology and mechanistic simulations using the BEEHAVE model. Our results replicated previous findings, which showed that imidacloprid selectively reduces pollen foraging at the colony level, with minimal impact on nectar foraging. Individually marked exposed honeybees exhibited prolonged pollen foraging trips, reduced pollen foraging frequency, and instances of drifting pollen foraging trips, likely due to impaired cognitive functions and altered metabolism. These behavioral changes at the individual level corroborated the previous model predictions derived from BEEHAVE, which highlights the value of combining experimental and simulation approaches to disentangle underlying mechanisms through which sublethal effects on individual foragers scale up to impact colony dynamics. Our findings have implications for future pesticide risk assessment, as we provide a robust feeding study design for evaluating pesticide effects on honeybee colonies and foraging in real landscapes, which could improve the realism of higher-tier ecological risk assessment.

This dataset comprises palynological counts on sediments from IODP Expedition 374 Site U1521 to the Ross Sea, collected on the RV JOIDES Resolution. Marine palynomorphs are counted in 23 samples, and 7 samples were counted for terrestrial palynomorphs (pollen and spores). Shipboard biostratigraphy and magnetostratigraphy suggests the samples are early Miocene in age (McKay et al., 2019, Proceedings of the International Ocean Discovery Program).

No description is available. Visit https://dataone.org/datasets/b6d69313dfe95c2c56f78b758115faea for complete metadata about this dataset.